-
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine
03 Feb 2026 13:01 GMT
…
1 Tablet
M/s Glenmark Pharmaceuticals Ltd.
16.40
28
Empagliflozin, … ml
M/s Akums Drugs & Pharmaceuticals Ltd./ M/s … -mentioned formulations i.e., “new drug” under paragraph 2(1)(u) …
-
Broker’s call: Glenmark Pharma (Add)
03 Feb 2026 12:59 GMT
… ,175
CMP: ₹1,955.85
Glenmark Pharmaceuticals’ revenue grew 15.1 per …
-
Indian drugmaker Mankind Pharma posts higher quarterly profit on strong chronic drugs demand
03 Feb 2026 12:47 GMT
… 3 (Reuters) – Indian drugmaker Mankind Pharma reported a higher third-quarter … strong domestic demand for its drugs used for treating long-term … on the sales of these drugs and comprise a large part … .47 Buy 29 0.98
Pharmaceuticals
Ltd
Glenmark 24.02 14.76 …
-
In the works—a tougher drug law to check opioid abuse
03 Feb 2026 03:19 GMT
… for India’s pharma market.
What are these drugs all about
The … pharmacists.
“DCGI is reviewing the proposal to include necessary provisions under Drugs … leading drugmakers Sun Pharma, Dr Reddy’s Laboratories, Abbott, Aurobindo Pharma and Glenmark on …
-
Glenmak expects Hengrui’s in-licensed drug to enter market from FY28
02 Feb 2026 16:28 GMT
New Delhi: Glenmark Pharmaceuticals expects its $1 billion buyout cancer drug, Trastuzumab Rezetecan ( … Glenn Saldanha, Chairman and MD Glenmark, said while addressing investors queries … on the therapy sales.
Glenmark obtained exclusive rights for select …
-
Exemption on drugs for cancer, rare disease: Patient-first or minimal benefits?
01 Feb 2026 17:09 GMT
… duties on personal imports of drugs, medicines and Food for … The medicines were from multinational drugmakers including Novartis, AstraZeneca, Eli Lilly … (BeOne Medicines (formerly BeiGene) / Glenmark Pharma (India partner)
Inotuzumab ozogamicin (Pfizer …
-
Budget 2026:27: Govt lifts custom duty on 17 drugs to curb price burden for cancer patients
01 Feb 2026 13:53 GMT
… on 17 key cancer drugs, including several biologic blockbusters … , talycabtagene autoleucel.
The drug is manufactured and marketed … South Asia, Bayer Pharmaceuticals.
List of drugs given duty waiver … inhibitor
11
Tislelizumab
Tevimbra
Glenmark (in-licensed)
PD …
-
Stocks To Watch On February 1: Bajaj Auto, BoB, Sun Pharma, SAIL, IDFC First Bank and more
31 Jan 2026 19:48 GMT
… 12.5% from 18.6%.
Glenmark Pharma | The pharma company's Q3 … from 7%.
MedPlus Health | The pharma company's Q3 net … .8% from 18%.
Sun Pharma | The pharma company is set to report … on Saturday, January 31. Sun Pharma';s formulation sales in …
-
Glenmark posts ₹3,900 cr in Q3 FY26, net profit soars 16%
31 Jan 2026 04:13 GMT
… scaling across markets, while Winlevi (drug for acne vulgaris) is gaining … Glenn Saldanha, Chairman and MD, Glenmark Pharmaceuticals.
Moving forward, Saldanha added, “Our … $1.09 billion in-licensed drug) and Aumolertinib will strengthen the …
-
Glenmark Q3 profit rises 16% on strong India, US performance
30 Jan 2026 20:02 GMT
Glenmark Pharmaceuticals Ltd has reported a 16% … to Rs 403 crore, the drug maker said in a statement … Q3 FY26.
During the quarter, Glenmark also received a positive regulatory … from the US Food and Drug Administration for its Monroe, North …
About
© 1995-2026